Mainz Biomed Recaps First Half of 2024 Achievements
Jul 3, 2024
Cancer Investment Portfolios
MiNK Therapeutics Schedules Virtual Annual Shareholders Meeting Amidst Pioneering Cancer Therapies Development
Jun 5, 2024
AIM ImmunoTech Commences Key Study for Pancreatic Cancer Treatment in Partnership with AstraZeneca
Feb 15, 2024
Johnson & Johnson Acquires Ambrx Biopharma, Enhancing Cancer Drug Portfolio Amidst Harpoon Therapeutics Advancements
Jan 9, 2024
Fortis Healthcare Inaugurates Advanced Blood Cancer Treatment Institute
Jan 6, 2024
Enveric Biosciences Reveals Decline in Revenue for Q3 2023 Amid Advancements of Psychedelics into Clinical Trials
Nov 15, 2023
Aethlon Medical AEMD Commences Coverage by StockNews.com Analysts
Nov 13, 2023